Completed
A Study of Galcanezumab (LY2951742) in Participants with Cluster Headache
I5Q-MC-CGAR - ClinicalTrials.gov - NCT02797951
The main purpose of this study is to assess the long-term safety and tolerability of galcanezumab administered up to once monthly in participants with episodic or chronic cluster headache who have completed study I5Q-MC-CGAL (NCT02397473) or study I5Q-MC-CGAM (NCT02438826).
How long will I be in the trial?
Your participation could last until approximately August 2020 and include monthly visits
Completed
A Study of Galcanezumab (LY2951742) in Participants with Cluster Headache
I5Q-MC-CGAR - ClinicalTrials.gov - NCT02797951
The main purpose of this study is to assess the long-term safety and tolerability of galcanezumab administered up to once monthly in participants with episodic or chronic cluster headache who have completed study I5Q-MC-CGAL (NCT02397473) or study I5Q-MC-CGAM (NCT02438826).
How long will I be in the trial?
Your participation could last until approximately August 2020 and include monthly visits
Key Requirements
Age :
18+
Sex:
All
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Age
18+
Sex
All
Participants must
Participant must have participated in and completed either study CGAL or study CGAM
Participant must be reliable to follow all study procedures, keep all study visits, and be compliant with study requirements - Female participant must not be pregnant or nursing
Participants must NOT
Participant must not be currently enrolled in or discontinued within the last 30 days from, a clinical trial involving any investigational drug or device (with the exception of study CGAL or study CGAM)
Trial Summary
Conditions the trial is for
Chronic Cluster Headache, Episodic Cluster Headache, Cluster Headache
What the trial is testing?
Galcanezumab, LY2951742
Could I receive a Placebo?
no
Enrollment Goal
300
Trial Dates
July 2016 - January 2021
Trial Phase
3
Enter your postal code to find the nearest site
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Age
18+
Sex
All
Participants must
Participant must have participated in and completed either study CGAL or study CGAM
Participant must be reliable to follow all study procedures, keep all study visits, and be compliant with study requirements - Female participant must not be pregnant or nursing
Participants must NOT
Participant must not be currently enrolled in or discontinued within the last 30 days from, a clinical trial involving any investigational drug or device (with the exception of study CGAL or study CGAM)
Trial Summary
Conditions the trial is for
Chronic Cluster Headache, Episodic Cluster Headache, Cluster Headache
What the trial is testing?
Galcanezumab, LY2951742
Could I receive a Placebo?
no
Enrollment Goal
300
Trial Dates
July 2016 - January 2021
Trial Phase
3
Not the right fit? Sign up to receive updates on new trials.
Trial Locations
Hide locations not currently recruiting
Enter your postal code to see sites near you
By clicking the checkbox and using the map, you agree to allow Google Maps to collect your personal information in accordance with their Privacy Policy
Resources
